Industrial fermentation is a critical bio-based process for the production of chemicals and enzymes. Caribou Biosciences' CRISPR-Cas technology provides precision tools to improve microbial production strains and generate better cell factories for fermentation. Our CRISPR-Cas technology will also unlock the potential of microbes to bioproduce chemicals and enzymes never before produced by fermentation. Potential new bio-based materials run the gamut from fragrances and flavors to industrial cleaning and transportation.
In the health care industry, many life-saving products, such as recombinant therapeutic proteins, vaccines, and gene therapy vectors, are produced from large-scale cell culture systems. Our technology and capabilities can improve these cell systems to yield larger quantities and higher qualities of therapeutic biomaterials.
In Depth - Industrial Biotech
CRISPR-Cas technology improves the microbial production strains used in the bioproduction of chemicals and enzymes from fragrances and flavors to industrial cleaning and transportation. The technology also improves cell culture systems used to produce therapeutic proteins, vaccines, and gene therapy vectors.